Answers are grounded in this paper and cite their sources.
Prospective cohort study reports risk factors for postoperative SYNECHIAE in patients with angle-closure disease after phacoemulsification and viscogonioplasty.
AIM: To compare surgical efficacy based on residual peripheral anterior synechiae (PAS) extent after viscogonioplasty (VGP) combined with phacoemulsification and intraocular lens implantation (PEI) in patients with primary angle-closure disease (PACD) and identify risk factors for extensive postoperative PAS. METHODS: This prospective cohort study included 73 eyes of 61 patients with PACD undergoing PEI with VGP. Patients were divided into Group A (PAS<90°, n=39) and Group B (90°≤PAS≤180°, n=34) based on PAS extent at the end of surgery. PAS progression rates were assessed using a linear mixed-effects model. Logistic regression analyzed risk factors for PAS≥180° at 12mo postoperatively. RESULTS: Both groups showed significant PAS progression at 12mo (P<0.001). Group A had smaller PAS extent than Group B at all time points (P<0.001). PAS progression rates were similar between groups (P=0.335). No significant differences were found in intraocular pressure (IOP), IOP-lowering medications, or surgical success rates (P>0.05). Female [odds ratio (OR)=0.211, P=0.046], preoperative medication number (OR=1.017, P=0.029), and PAS extent at the end of surgery (OR=1.017, P=0.018) were risk factors for PAS≥180° at 12mo. CONCLUSION: Residual PAS extent at the end of surgery predicts postoperative extensive PAS formation but has limited effect on PAS progression rate and IOP control. Female, multiple preoperative IOP-lowering medications, and larger residual PAS extent are independent risk factors for extensive PAS at 12mo postoperatively.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: